Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the zorbtive or serostim market grown in recent years?

The market size for zorbtive or serostim has experienced a XX (HCAGR) in the recent past. The significant rise is projected to move from a value of $XX million in 2024 to a worth of $XX million in 2025, yielding a compound annual growth rate (CAGR) of XX%. The expansion during the historic phase is due to the advancement in early diagnosis and detection, increase in the creation of unique therapies and drug treatments, a boost in the uptake of hormone replacement therapies, enhancement in healthcare accessibility and advanced treatment alternatives, and an increase in the provision of injectable growth hormone prescriptions.

How is the zorbtive or serostim market size expected to evolve during the forecast period?

The market size of zorbtive or serostim is anticipated to witness a compound annual growth rate (CAGR) of XX% in the upcoming years, increasing to a valuation of $XX million by 2029. The projected growth in this period is linked to the growing popularity of telemedicine platforms, the escalating demand for personalized and target-specific treatments, an expansion in research and development initiatives, a rising geriatric population, and an uptick in instances of growth hormone deficiencies. The forecast period is set to see a pivot towards precision medicine in hormone therapy, the adoption of home-based injection appliances for the sake of patient convenience, an increase in the popularity of biosimilars as a cost-effective option, progress in drug delivery technology, and the widening of market reach in developing economies.

Get your zorbtive or serostim market report here!

https://www.thebusinessresearchcompany.com/report/zorbtive-or-serostim-global-market-report

Which key drivers are propelling the zorbtive or serostim market’s growth?

The expected increase in HIV patients is anticipated to fuel the expansion of the zorbtive or serostim market. HIV is a virus that weakens the immune system by specifically attacking CD4 cells that are crucial for combating infections. The escalation in HIV prevalence is related to factors like increased unprotected sexual activity, limited access to preventative healthcare, poor awareness and education, and obstacles in HIV testing and treatment, particularly in high-risk populations. Zorbtive or serostim aids HIV patients by addressing the HIV-associated wasting syndrome, encouraging weight gain, boosting lean body mass, and enhancing overall physical performance and life quality for patients whose immune systems are compromised by the virus. For example, the US-based government agency, Centers for Disease Control and Prevention, estimated in April 2024 that 31,800 new HIV infections took place in the U.S. in 2022. Of these, gay, bisexual, and other men who reported male-to-male sexual contact accounted for 67% (21,400) of new cases and 83% of infections among all men. Heterosexual contact accounted for 22% (7,000) of new infections, including 7% (2,100) among men and 15% (4,900) among women. Consequently, the rise in HIV patients is propelling the zorbtive or serostim market’s growth.

What are the market segments in the zorbtive or serostim industry?

The zorbtive or serostim market covered in this report is segmented –

1) By Indication: Short Bowel Syndrome; HIV-Associated Wasting

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By End User: Adult Patients; Geriatric Patients

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20364&type=smp

Which leading companies are shaping the growth of the zorbtive or serostim market?

Major companies operating in the zorbtive or serostim market are EMD Serono Inc.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20364

Which geographic areas are influencing the growth of the zorbtive or serostim market?

North America was the largest region in the zorbtive or serostim market in 2024. The regions covered in the zorbtive or serostim market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Biosimilar Growth Hormones Global Market Report 2025

https://thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Global Biosimilar Hormones Global Market Report 2025

https://thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: